Zepp Health Corporation (ZEPP) Key Metrics
ZEPP valuation today
Trailing 12 months · as of October 17, 2026- Market cap
- $44.3M
- Enterprise value
- $238.5M
- P/E (TTM)
- —
- Forward P/E
- 3.1
- PEG ratio
- —
- Price / sales
- 0.2
- Price / book
- 0.3
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 1.81
ZEPP key metrics, 2024–2025
Fiscal year ended December 31, 2025 · U.S. dollarsZEPP returns How much profit the business earns on the capital it uses.
ZEPP financial health Debt, liquidity and how easily interest is covered.
ZEPP efficiency & capital use Working capital cycle and where the cash goes.
ZEPP valuation history
ZEPP returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
ZEPP debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
ZEPP cash returned to shareholders
ZEPP price vs earnings per share
ZEPP key metrics
2024–2025| 2025 | 2024 | |
|---|---|---|
| Valuation | ||
| Market capitalization | — | $42.1M |
| Enterprise value | — | $555.9M |
| Price / sales | — | 0.0 |
| Price / book | — | 0.0 |
| EV / sales | — | 0.4 |
| Earnings yield | — | −1,317.2% |
| Free cash flow yield | — | −61.5% |
| Dividend yield | — | 0.0% |
| Shareholder yield (dividends + buybacks) | — | 5.4% |
| Share price at fiscal year-end | $26.94 | $2.60 |
| Per share | ||
| Revenue per share | — | $82.41 |
| Earnings per share | — | −$34.25 |
| Operating cash flow per share | — | −$1.51 |
| Free cash flow per share | — | −$1.60 |
| Cash per share | — | $50.40 |
| Book value per share | — | $113.49 |
| Tangible book value per share | — | $105.97 |
| Dividends per share | — | $0.00 |
| Capex per share | — | $0.09 |
| Debt per share | — | $82.16 |
| Shares outstanding | — | 16.2M |
| Returns & profitability | ||
| Return on equity (ROE) | −16.8% | −30.2% |
| Return on invested capital (ROIC) | −7.0% | −11.6% |
| Return on assets (ROA) | −7.2% | −14.4% |
| Return on tangible assets | −7.4% | −14.8% |
| Free cash flow margin | −10.2% | −1.9% |
| Financial health | ||
| Total debt | $1.59B | $1.33B |
| Cash & short-term investments | $789.7M | $815.5M |
| Net debt | $804.8M | $513.9M |
| Debt / equity | 1.06 | 0.72 |
| Debt / assets | 0.40 | 0.34 |
| Current ratio | 1.02 | 1.29 |
| Quick ratio | 0.77 | 1.00 |
| Interest coverage | -5.1 | -8.5 |
| Working capital | $46.7M | $410.2M |
| Invested capital | $2.30B | $2.35B |
| Tangible asset value | $1.34B | $1.72B |
| Net current asset value | −$397.0M | −$177.4M |
| Graham net-net per share | — | −$34.45 |
| Capital allocation | ||
| Dividends paid | — | $0 |
| Share buybacks (net) | $8.7M | $2.3M |
| Capex / revenue | 0.3% | 0.1% |
| Capex / depreciation | 0.17 | 0.04 |
| Stock-based compensation / revenue | 1.0% | 0.4% |
| R&D / revenue | 17.5% | 25.3% |
| SG&A / revenue | 4.6% | 39.1% |
| Efficiency | ||
| Days sales outstanding | 109.8 | 158.1 |
| Days of inventory on hand | 152.7 | 184.4 |
| Days payables outstanding | 155.1 | 165.8 |
| Cash conversion cycle (days) | 107.4 | 176.7 |
| Receivables turnover | 3.32 | 2.31 |
| Payables turnover | 2.35 | 2.20 |
| Inventory turnover | 2.39 | 1.98 |
| Asset turnover | 0.46 | 0.35 |
| Average receivables | $546.1M | $577.7M |
| Average payables | $468.8M | $372.8M |
| Average inventory | $461.6M | $414.5M |
| Intangibles / total assets | 4.1% | 3.2% |
Computed from ZEPP's annual financial statements (latest annual report filed April 24, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
ZEPP valuation and financial ratios
Zepp Health earned a return on equity of −16.8% and a return on invested capital of −7.0% in fiscal 2025. It ended the year with $1.6 billion of debt and $789.7 million in cash and short-term investments, net debt of $804.8 million. It returned $8.7 million to shareholders: $0 in dividends and $8.7 million in share buybacks.
See the ZEPP income statement, the ZEPP chart for price history, or the ZEPP stock overview for the latest quote and news.
ZEPP key metrics FAQ
What is Zepp Health's return on equity?
Zepp Health's return on equity (ROE) was −16.8% in fiscal 2025: net income of -$280.9 million on average shareholders' equity of $1.7 billion.
What is Zepp Health's ROIC?
Zepp Health's return on invested capital was −7.0% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Zepp Health have?
Zepp Health had total debt of $1.6 billion at the end of fiscal 2025, a debt-to-equity ratio of 1.06.
Does Zepp Health buy back its shares?
Yes. Zepp Health spent $8.7 million on net share repurchases in fiscal 2025.
What is Zepp Health's current ratio?
Zepp Health's current ratio was 1.02 at the end of fiscal 2025: current assets were 1.02 times current liabilities.